PATENT CLAIM ANALYSIS

Application Number: 16131003
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["530", "350000"]

Abstract:
The invention herein disclosed is related to epitopes useful in methods of diagnosing, treating, and preventing coeliac disease. Therapeutic compositions which comprise at least one epitope are provided.

Claim (Index 50):
A method of diagnosing coeliac disease, or susceptibility to coeliac disease, in an individual comprising determining the presence of an antibody that binds to an epitope of an epitope comprising sequence as defined in  claim 38  in a sample from the individual, the presence of the antibody indicating that the individual has, or is susceptible to, coeliac disease.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.06667
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14630004', '13541864', '10516837', '10089700', '11630818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6730444059034869
- 35 USC 102 Novelty (BERT): 0.5777371924550649
- Combined Prediction Score: 0.6635136845586447
- Mean Citation Score: 413.16597999999993
- Max Citation Score: 487.38614
- Similarity Product: 395.09184259472846

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test